Literature DB >> 6293112

Regulation of the immune response to antigens on the malignant cell surface.

J A Drebin, L L Perry, R Carter, M I Greene.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6293112     DOI: 10.1007/bf00199795

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  78 in total

1.  Characterization of T antigens in polyoma-infected and transformed cells.

Authors:  M A Hutchinson; T Hunter; W Eckhart
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

Review 2.  Suppressor cells: permitters and promoters of malignancy?

Authors:  D Naor
Journal:  Adv Cancer Res       Date:  1979       Impact factor: 6.242

Review 3.  Passive immunotherapy of cancer in animals and man.

Authors:  S A Rosenberg; W D Terry
Journal:  Adv Cancer Res       Date:  1977       Impact factor: 6.242

4.  The genetic and cellular basis of antigen and receptor stimulated regulation.

Authors:  M I Greene; M S Sy; A Nisonoff; B Benacerraf
Journal:  Mol Immunol       Date:  1980-07       Impact factor: 4.407

5.  T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.

Authors:  E S Dye; R J North
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

6.  T cell subset interactions in the regulation of syngeneic tumor immunity.

Authors:  L L Perry; M I Greene
Journal:  Fed Proc       Date:  1981-01

7.  In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.

Authors:  J T Rosenbaum; N E Adelman; H O McDevitt
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

8.  Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex.

Authors:  T Tada; M Taniguchi; C S David
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

9.  Ly phenotype of cytotoxic T cells for syngeneic tumor.

Authors:  H Shiku; T Takahashi; M A Bean; L J Old; H F Oettgen
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

10.  Analysis of T cell hybridomas. I. Characterization of H-2 and Igh-restricted monoclonal suppressor factors.

Authors:  M Minami; K Okuda; S Furusawa; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Temporal changes of suppressor T lymphocytes and cytotoxic T lymphocytes in syngeneic murine malignant gliomas.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Namba; M Hanaoka
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

3.  Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells.

Authors:  R J North; I Bursuker
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

4.  Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.

Authors:  F Cozzolino; M Torcia; A M Carossino; R Giordani; C Selli; G Talini; E Reali; A Novelli; V Pistoia; M Ferrarini
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

5.  A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes.

Authors:  Y Okada; G Yahata; S Takeuchi; T Seidoh; K Tanaka
Journal:  Jpn J Cancer Res       Date:  1989-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.